THE BEST OF ADA SOUTH EAST ASIA

Webinar 1

Debate: The Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus—Is There Value?

Athena Philis-Tsimikas, MD

Monday, July 20th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Dr. Zanariah Hussein - Important CME notice: For Malaysia, Webinar 1: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Reduction of Hypoglycemia by New Therapies in Clinical Trials

Simon R. Heller MD, FRCP

Monday, July 20th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Dr. Zanariah Hussein - Important CME notice: For Malaysia, Webinar 1: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Webinar 2

Weekly Basal Insulin – Wave of the Future?

Jay H. Shubrook DO FACOFP, FAAFP

Monday, June 29th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Prof. AK Azad Khan - Important CME notice: For Malaysia, Webinar 2: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

The “Legacy Effect” in Diabetes—Are There Long-Term Benefits of Short-Term Tight Glycemic Management?

Derek Leroith, MD, PhD

Monday, June 29t from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Prof. AK Azad Khan - Important CME notice: For Malaysia, Webinar 2: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Webinar 3

Tailoring Treatment Options Based Upon Diabetes Comorbidities

Kenneth Cusi, MD, FACP, FACE

Monday, July 6th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Prof. DR. Dr. Ketut Suastika, SpPD-KEMD (Chair, PERKENI) - Important CME notice: For Malaysia, Webinar 3 & 4: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Which Medication is Best to Prevent a Cardiovascular Event in a Patient with Type 2 Diabetes and Established or at High Risk for Heart Disease?

Andrew JM Boulton, MD, DSc (Hon), FACP, FICP, FRCP

Monday, July 6th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderator: Prof. DR. Dr. Ketut Suastika, SpPD-KEMD (Chair, PERKENI) - Important CME notice: For Malaysia, Webinar 3 & 4: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Webinar 4

Interpreting Cardiovascular Outcomes Trials – Implications for Practice

Michelle Magee, MD, MBBCh, BAO, LRCPSI

Monday, July 13th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderators: Jeremy F. Robles and Prof. Tint Swe Latt - Important CME notice: For Malaysia, Webinar 3 & 4: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Reconciling Guideline Recommendations for Cardiovascular Risk and Disease Management in Type 2 Diabetes

Richard E. Pratley, MD

Monday, July 13th from 6:00 PM-7:30 PM (Malaysia Standard Time); Moderators: Jeremy F. Robles and Prof. Tint Swe Latt - Important CME notice: For Malaysia, Webinar 3 & 4: Each participant receives 1 CPD point from MMA, for Malaysia doctors - For Singapore, pending SMC confirmation for CME points.

Register for this event

Legal Notice
Copyright 2020